Jinhe Biotechnology CO., LTD. (SHE:002688)
China flag China · Delayed Price · Currency is CNY
5.82
-0.11 (-1.85%)
May 20, 2026, 3:04 PM CST

SHE:002688 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Revenue
2,9952,8782,3662,1682,1172,072
Other Revenue
--4.996.045.825.8
2,9952,8782,3712,1742,1232,078
Revenue Growth (YoY)
20.94%21.41%9.04%2.42%2.15%14.51%
Cost of Revenue
1,9801,9041,6411,5721,5451,472
Gross Profit
1,015974.5729.97602.51577.47605.66
Selling, General & Admin
545.07527.75401.98367.95352.78316.37
Research & Development
113.39116.55947482.2872.25
Other Operating Expenses
-7.6-7.758.145.827.7512.15
Operating Expenses
652.48636.54518.11454.08444.34402.65
Operating Income
362.65337.96211.85148.43133.13203.01
Interest Expense
-0.15--80.34-60.03-36.41-52.34
Interest & Investment Income
1.79-6.98.371.91.72
Currency Exchange Gain (Loss)
--8.928.8540.34-8.83
Other Non Operating Income (Expenses)
-108.14-101.02-28.48-7.33-15.79-4.87
EBT Excluding Unusual Items
256.14236.94118.8598.29123.18138.68
Impairment of Goodwill
---39.77-5.62-7.74-11.04
Gain (Loss) on Sale of Investments
-2.53-2.4-1.22-1.52-3.94-
Gain (Loss) on Sale of Assets
-2.67-2.660.19-0.36-0.254.87
Asset Writedown
-194.43-192.74-1.11-0.93-0.46-1.28
Other Unusual Items
--20.8311.658.0511.69
Pretax Income
56.5239.1597.78101.5118.84142.91
Income Tax Expense
55.9450.1313.467.060.7320.82
Earnings From Continuing Operations
0.57-10.9884.3294.43118.11122.09
Minority Interest in Earnings
38.1638.5415.88-7.98-42.5-28.1
Net Income
38.7427.56100.286.4675.6293.99
Net Income to Common
38.7427.56100.286.4675.6293.99
Net Income Growth
-63.52%-72.50%15.90%14.34%-19.55%-19.89%
Shares Outstanding (Basic)
780781774780780696
Shares Outstanding (Diluted)
780781774780780696
Shares Change (YoY)
1.00%0.81%-0.76%-0.01%12.16%6.74%
EPS (Basic)
0.050.040.130.110.100.14
EPS (Diluted)
0.050.040.130.110.100.14
EPS Growth
-63.88%-72.72%16.79%14.34%-28.27%-24.94%
Free Cash Flow
94.05148.64136.18-258.45-277.69-230.74
Free Cash Flow Per Share
0.120.190.18-0.33-0.36-0.33
Dividend Per Share
--0.1000.1000.100-
Gross Margin
33.90%33.86%30.79%27.71%27.20%29.15%
Operating Margin
12.11%11.74%8.94%6.83%6.27%9.77%
Profit Margin
1.29%0.96%4.23%3.98%3.56%4.52%
Free Cash Flow Margin
3.14%5.17%5.75%-11.89%-13.08%-11.10%
EBITDA
603.77567.89397.04321.3282.31333.98
EBITDA Margin
20.16%19.73%16.75%14.78%13.30%16.07%
D&A For EBITDA
241.12229.94185.19172.86149.18130.97
EBIT
362.65337.96211.85148.43133.13203.01
EBIT Margin
12.11%11.74%8.94%6.83%6.27%9.77%
Effective Tax Rate
98.99%128.06%13.77%6.96%0.61%14.57%
Revenue as Reported
116.73-2,3712,1742,1232,078
Advertising Expenses
--27.7420.6412.165.36
Source: S&P Global Market Intelligence. Standard template. Financial Sources.